KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Shares Issued (2016 - 2025)

West Pharmaceutical Services' Shares Issued history spans 17 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Shares Issued changed 0.0% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $6.9 million, down 72.94%, while the annual FY2025 figure was $6.9 million, 72.94% down from the prior year.
  • Shares Issued for Q4 2025 was $1.5 million at West Pharmaceutical Services, down from $1.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $39.1 million in Q3 2023 and bottomed at -$35.5 million in Q4 2023.
  • The 5-year median for Shares Issued is $1.8 million (2023), against an average of $4.5 million.
  • The largest annual shift saw Shares Issued surged 1216.67% in 2021 before it plummeted 752.94% in 2024.
  • A 5-year view of Shares Issued shows it stood at $23.7 million in 2021, then crashed by 37.55% to $14.8 million in 2022, then tumbled by 339.86% to -$35.5 million in 2023, then skyrocketed by 104.23% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Shares Issued are $1.5 million (Q4 2025), $1.8 million (Q3 2025), and $1.7 million (Q2 2025).